Scientific Continuing Education
AustraliaPeptide Therapies in the Australian Regulatory Context
A private education portal for Australian clinicians, grounded in current TGA and Ahpra guidance on peptide and regenerative therapies.
Australian regulatory focus
Built for Australian medical practice
TGA scheduling & access
Understand how peptides are scheduled under the Poisons Standard, when they are considered unapproved therapeutic goods, and the lawful access pathways available in Australia.
Ahpra & advertising law
Navigate the Therapeutic Goods Advertising Code and Ahpra advertising guidelines that govern how Australian practitioners can communicate about peptide therapies.
State & territory practice
Apply clinical governance, consent, and prescribing expectations that apply across Australian states and territories, including compounding and personal importation considerations.